Alzheimer Disease, Early Onset: Disease Bioinformatics
Alzheimer's Disease (AD) is a neurological disease that is the most common cause of dementia. Early onset of the disease occurs in patients under the age of 65, which is approximately 5-10% of all diagnosed cases of Alzheimer's. The disease leads to memory loss, and in the later stages, an inability to perform daily activities. AD can occur in younger patients due to a mutation in the presenilin 1 (PSEN 1), presenilin 2 (PSEN 2), and amyloid precursor protein (APP) genes.
Alzheimer Disease, Early Onset Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Alzheimer Disease, Early Onset below!
For more information on how to use Laverne, please read the How to Guide.
We have 686 products for the study of Alzheimer Disease, Early Onset that can be applied to Chromatin Immunoprecipitation, Flow Cytometry, Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.